Investing.com -- BofA Securities analysts have downgraded GEA Group AG (ETR: G1AG) to “underperform” from “buy,” citing ...

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today reported financial results for the first quarter 2025 ...

Bank of America (BofA) analysts reaffirm a bullish outlook for data center and artificial intelligence (AI) infrastructure ...

Discover key insights from TTEC's Q1 2025 earnings call, emphasizing growth through AI, offshore expansion, and hyperscaler partnerships while ...

A recent survey from IBM has revealed that most executives are spending money on AI to stay ahead of the technology, despite ...

Gain insights from Vishay Intertechnology's Q1 2025 earnings, exploring steady revenues, growth in AI & smart grid demand, and strategic plans under ...

Meta Platforms has gained over 1,200% since 2012. The company is now investing heavily in artificial intelligence, bolstering ...

Despite the China headwinds and earnings questions, analysts are standing firmly in Nvidia’s corner. The stock holds a Strong Buy rating from 40 Wall Street analysts, with 34 calling it a Buy, five ...

During fiscal 2024, the company grew its GMV by 28% year-over-year to reach $100 billion. Moreover, management also noted ...

Nvidia shares have suffered under the threat of chip tariffs but the focus will turn to its coming earnings on May 28.

Dividend Challengers refers to US-listed companies that have raised their dividends every year for a minimum of five, and ...

The Big Tech trade is alive and well. That's one lesson from this earnings season, in which the market's biggest tech ...